Search UHS
UNIVERSAL HEALTH SERVICES INC
NYSE · CIK 352915
Last close175.72
Daily change+0.65 (0.37%)
10 Years gain+50.72%
Dividends TTM0.8 (+0.00%)
Dividend yield0.46%
Fundamental Analysis
UHS · STANDARD
SIC 8062 · Services-General Medical & Surgical Hospitals, NEC · Fiscal year end 1231
Fundamental
53.3Momentum
54.4Acceleration
54.4Confidence
86.0Annual Revenue16
Quarterly Revenue75
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth13.9 / 25
Quality18.5 / 25
Capital Efficiency10.6 / 20
Balance Sheet7.7 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 0.8739 percentage points.
Share count reductionDiluted share count declined 9.2781%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM13.27%OK
Revenue CAGR 3Y9.03%OK
Gross Margin100%OK
Operating Margin11.4%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC13.25%OK
Incremental Operating Margin 3Y22.18%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-9.28%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $17.36B | $17.36B | $1.99B | $1.86B | $849.25M | 100% | 11.48% | 4.89% | 13.32% | 64.46M |
| 2025 FY Dec 31, 2024 | $15.83B | $15.83B | $1.68B | $2.07B | $1.12B | 100% | 10.63% | 7.1% | 11.88% | 67.9M |
| 2025 FY Dec 31, 2023 | $14.28B | $14.28B | $1.18B | $1.27B | $524.74M | 100% | 8.23% | 3.67% | 8.34% | 70.13M |
| 2024 FY Dec 31, 2022 | $13.40B | $13.40B | $1.00B | $996.02M | $262.02M | 100% | 7.49% | 1.96% | 7.32% | 73.83M |
| 2023 FY Dec 31, 2021 | $12.64B | $12.64B | $1.36B | $883.70M | $28.04M | 100% | 10.78% | 0.22% | 10.89% | 83.69M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $17.91B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-340278, 0001193125-25-272385 |
| Revenue Growth TTM | 13.27% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-340278, 0001193125-25-272385 |
| Revenue CAGR 3Y | 9.03% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071676 |
| Revenue CAGR 5Y | 8.48% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-071676 |
| Gross Profit CAGR 3Y | 9.03% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071676 |
| Operating Income Growth | 22.67% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-340278, 0001193125-25-272385 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001193125-26-340278, 0001193125-25-272385 |
| Operating Margin | 11.4% | Operating Income / Revenue | OK | 0001193125-26-340278, 0001193125-25-272385 |
| ROIC | 13.25% | NOPAT / Average Invested Capital | OK | 0001193125-26-340278, 0001193125-25-272385 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-340278 |
| Interest Coverage | 13.53x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.12x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.03x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-340278 |